Press Releases August 13, 2026 Yarrow Bioscience Reports Second Quarter 2026 Financial Results and Provides Business Update Press Release July 27, 2026 Yarrow Bioscience Announces Closing of Merger with VYNE Therapeutics and Initiation of Dosing in Phase 2a/2b Trial of YB-101, a Potential First-in-Class Treatment for Graves’ Disease and Thyroid Eye Disease Press Release December 17, 2025 VYNE Therapeutics and Yarrow Bioscience Announce Merger Agreement Press Release